[HTML][HTML] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

…, JA Anderson, B Celli, GT Ferguson… - … England Journal of …, 2007 - Mass Medical Soc
Background Long-acting beta-agonists and inhaled corticosteroids are used to treat chronic
obstructive pulmonary disease (COPD), but their effect on survival is unknown. Methods We …

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a …

…, P Nair, S Korn, K Ohta, M Lommatzsch, GT Ferguson… - The Lancet, 2016 - thelancet.com
Background Benralizumab is a humanised, afucosylated, anti-interleukin-5 receptor α
monoclonal antibody that induces direct, rapid, and nearly complete depletion of eosinophils. We …

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

…, NE Thomas, JA Anderson, GT Ferguson… - American journal of …, 2008 - atsjournals.org
Rationale: Chronic obstructive pulmonary disease (COPD) is characterized by an accelerated
decline in lung function. No drug has been shown conclusively to reduce this decline. …

Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program

GT Ferguson, PL Enright, AS Buist, MW Higgins - Chest, 2000 - Elsevier
… Following an extensive literature review, Gary Ferguson developed the first draft of this
report in early 1998, which then was reviewed by the NLHEP spirometry subcommittee. The …

An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease

…, LM Fabbri, B Fahy, GT Ferguson… - American journal of …, 2015 - atsjournals.org
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity,
mortality, and resource use worldwide. The goal of this Official American Thoracic Society (…

Adherence to inhaled therapy, mortality and hospital admission in COPD

…, JA Anderson, PMA Calverley, B Celli, GT Ferguson… - Thorax, 2009 - thorax.bmj.com
Background: Little is known about adherence to inhaled medication in chronic obstructive
pulmonary disease (COPD) and the impact on mortality and morbidity. Methods: Data on drug …

Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study

ED Bateman, GT Ferguson, N Barnes… - European …, 2013 - Eur Respiratory Soc
We investigated the efficacy and safety of dual bronchodilation with QVA149 versus its
monocomponents indacaterol and glycopyrronium, tiotropium and placebo in patients with …

[HTML][HTML] Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled …

…, PMA Calverley, B Celli, JA Anderson, GT Ferguson… - Respiratory …, 2009 - Springer
Background The efficacy of inhaled salmeterol plus fluticasone propionate (SFC) in patients
with severe or very severe COPD is well documented. However, there are only limited data …

[HTML][HTML] Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD

KF Rabe, FJ Martinez, GT Ferguson… - … England Journal of …, 2020 - Mass Medical Soc
Background Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β 2 -agonist (LABA) for chronic obstructive …

Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study

GT Ferguson, PMA Calverley, JA Anderson… - Chest, 2009 - Elsevier
… Author links open overlay panel Gary T. Ferguson MD, FCCP a , Peter MA Calverley MD
b , … Ferguson served as the primary author, reviewing all data, and wrote the article. Dr. …